Exome sequencing revealed USP9X and COL2A1 mutations in a large family with multiple epiphyseal dysplasia

Bone. 2022 Oct:163:116508. doi: 10.1016/j.bone.2022.116508. Epub 2022 Jul 28.

Abstract

Diagnosis of rare skeletal diseases is based primarily on clinical phenotype and radiographic analysis. Genetic etiology of these heterogeneous diseases remains largely unknown. Here, we report the identification of two genomic mutations using exome sequencing from patients with multiple epiphyseal dysplasia (MED) of an unusual family in autosomal dominant and X-linked inheritance. A dominant mutation (c.2224G > A; p.Gly687Ser) in the known causal COL2A1 gene was identified in three patients with MED, deformed femoral heads and vertebral dysplasia. Furthermore, a hemizygous mutation (c.2830G > A; p.Ala944Thr) in the USP9X gene was identified in the fourth patient with short stature, MED, deformed femoral head, thoracic and lumbar platyspondyly, right ankle condyle dysplasia, and subchondral sclerosis. This is the first identification of an X-linked candidate causative gene in a patient with MED, suggesting a new clinical entity. Our findings shed a new light on the role of USP9X in MED-associated disorders.

Keywords: Exome sequencing; Multiple epiphyseal dysplasia; USP9X; Ubiquitin-specific protease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Collagen Type II
  • Exome
  • Exome Sequencing
  • Humans
  • Mutation
  • Osteochondrodysplasias*
  • Pedigree
  • Ubiquitin Thiolesterase

Substances

  • COL2A1 protein, human
  • Collagen Type II
  • USP9X protein, human
  • Ubiquitin Thiolesterase